AbbVie
(NYSE) ABBV
AbbVie Financials at a Glance
Market Cap
$369.26B
Revenue (TTM)
$61.16B
Net Income (TTM)
$4.23B
EPS (TTM)
$2.36
P/E Ratio
88.44
Dividend
$6.65
Beta (Volatility)
0.34 (Low)
Dividend
$6.65
Beta (Volatility)
0.34 (Low)
Price
$208.80
Volume
181,565
Open
$214.21
Price
$208.80
Volume
181,565
Open
$214.21
Previous Close
$208.80
Daily Range
$207.71 - $214.53
52-Week Range
$164.39 - $244.81
Dividend
$6.65
Beta (Volatility)
0.34 (Low)
Price
$208.80
Volume
181,565
Open
$214.21
Previous Close
$208.80
Daily Range
$207.71 - $214.53
52-Week Range
$164.39 - $244.81
ABBV News
ABBV: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout AbbVie
Industry
Biotechnology
Sector
Health CareEmployees
57,000
CEO
Robert A. Michael, MBA, CPA
Website
www.abbvie.comHeadquarters
North Chicago, IL 60064-6400, US
ABBV Financials
Key Financial Metrics (TTM)
Gross Margin
73%
Operating Margin
27%
Net Income Margin
7%
Return on Equity
15222%
Return on Capital
18%
Return on Assets
3%
Earnings Yield
1.13%
Dividend Yield
0.03%
Payout Ratio
2.76%
Stock Overview
Market Cap
$369.26B
Shares Outstanding
1.77B
Volume
181.56K
Short Interest
0.00%
Avg. Volume
7.38M
Financials (TTM)
Gross Profit
$51.20B
Operating Income
$21.21B
EBITDA
$28.29B
Operating Cash Flow
$19.03B
Capital Expenditure
$1.21B
Free Cash Flow
$17.82B
Cash & ST Invst.
$5.26B
Total Debt
$69.07B
AbbVie Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$16.62B
+10.0%
Gross Profit
$13.96B
+30.4%
Gross Margin
84.02%
N/A
Market Cap
$369.26B
N/A
Market Cap/Employee
$6.71M
N/A
Employees
55,000
N/A
Net Income
$1.82B
+8354.5%
EBITDA
$16.03B
+2896.9%
Quarterly Fundamentals
Net Cash
$63.62B
-2.1%
Accounts Receivable
$12.59B
+15.3%
Inventory
$4.95B
+18.4%
Long Term Debt
$60.32B
-1.2%
Short Term Debt
$8.55B
+25.7%
Return on Assets
3.15%
N/A
Return on Invested Capital
18.02%
N/A
Free Cash Flow
$4.89B
-27.6%
Operating Cash Flow
$5.22B
-26.0%